The City of Hope-Spectrometer clinic team is laying the groundwork for a Raman system to assess cancer margins in vivo and in real time. The final device will be placed into the breast, liver, or prostate and, upon recognition of cancer, ablate the malignant tissue. The team’s focus has been to collect and analyze spectra of human tissue to extract features that indicate if the tissue is malignant.